U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07171983) titled 'A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis' on Sept. 11.
Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and drug levels of BMS-986454 in participants with Rheumatoid Arthritis
Study Start Date: Jan. 22, 2026
Study Type: INTERVENTIONAL
Condition:
Rheumatoid Arthritis
Intervention:
DRUG: BMS-986454
Specified dose on specified days
OTHER: Placebo
Specified dose on specified days
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Bristol-Myers Squibb
Disclaimer: Curated by HT Syndication....